Nirmala Bhoo shared a post on LinkedIn:

“For three incredible days, I had the privilege to join forces with over 20 dynamic key cancer stakeholders representing various disciplines and sectors in Malaysia, including the Ministry of Health, academia, local cancer NGOs, armed forces, and the Ministry of Women, Family, and Community Development.

Together, we embarked on a journey to craft a visionary 10-year roadmap towards downstaging of breast cancer in Malaysia. From brainstorming sessions to lively debates, we hashed out priority action areas and sketched specific activities across health promotion, screening, timely breast cancer diagnosis, comprehensive management, and data surveillance.

And you know what? Along the way, I found more than just colleagues – developing some real friendships that added an extra sparkle to our mission!

Also, on a personal note, I’m over the moon to report that our push for gender-sensitive workforce planning got a resounding thumbs-up! Breaking down gender-related barriers to breast and cervical cancer screening? You betcha!

A huge shoutout to Bahagian Pembangunan, Kesihatan Keluarga, Ministry of Health Malaysia, especially Dr. Shazimah Abdul Samad for orchestrating this stellar workshop!

This exercise has been an exhilarating reminder of the power of teamwork and big dreams..”

Source: Nirmala Bhoo/LinkedIn

Nirmala Bhoo-Pathy is as a Professor of Epidemiology in the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, and practices as a public health physician in Universiti Malaya Medical Centre, Malaysia. She is also a visiting scholar at Queen’s University Belfast, United Kingdom since 2014. Dr Bhoo Pathy’s career is focused on optimizing life after cancer in resource-limited settings through research and advocacy.

Dr Bhoo Pathy was the principal investigator of phase III of the ASEAN CosTs In ONcology (ACTION) study, comprising close to 10,000 cancer patients from eight low-and middle-income member countries of the Association of South East Asian Nations (ASEAN). She currently serves in two Lancet Commissions: the Lancet Commission on Women and Cancer and the Lancet Commission on Cancer and Health Systems.

As the founder and scientific lead of a solution-oriented research group ‘Well with Cancer in Malaysia (WeCan@MY) https://spm.um.edu.my/wecan@my/ in the Department of Social and Preventive Medicine, Nirmala Bhoo-Pathy currently oversees a wide range of studies on cancer care, cancer control and cancer policy, locally and globally.